Clinical Trials on Percutaneous Tracheostomy in Canada

Total 25 results

University of Alberta

Withdrawn

Electrically Guided Needle Insertion: ICU Study

Percutaneous Tracheostomy

Canada
University of Alberta
Alberta Innovates Health Solutions

Not yet recruiting

Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy (DECIDE-T)

Tracheostomy

Canada
Université de Sherbrooke

Not yet recruiting

Decannulation of Tracheostomy Cannula Based on Suctioning Frequency and High-flow Oxygen Protocol in the Intensive Care Unit (DECAP-ICU)

Tracheostomy Weaning

Canada
Université de Sherbrooke

Recruiting

Primary vs Secondary Closure of Tracheo-cutaneous Fistulas (TRACH)

Tracheostomy | Tracheostomy Complication | Post Tracheostomy Complications

Canada
Population Health Research Institute

Recruiting

Higher vs. Lower Dose Heparin for PCI (HD-PCI)

Cardiovascular Diseases | Percutaneous Coronary Intervention

Canada
University of British Columbia
Vancouver Coastal Health; VGH and UBC Hospital Foundation

Completed

The StoneBreakerTM Trial

Percutaneous Nephrolithotripsy

Canada
Ottawa Heart Institute Research Corporation

Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Percutaneous Coronary Intervention | Ticagrelor | Antiplatelet Therapy | Stable Coronary Syndrome

Canada
Portola Pharmaceuticals

Completed

A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI (INNOVATE-PCI)

Percutaneous Coronary Intervention

United States, Austria, Canada, Germany, Poland
Sanofi

Completed

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention (SEPIA-PCI)

Angioplasty, Transluminal, Percutaneous Coronary

United States, Spain, Belgium, Canada, South Africa, Netherlands, Germany, France, Czech Republic, Slovakia
Hopital du Sacre-Coeur de Montreal

Completed

H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel

Coronary Artery Disease | Elective Percutaneous Coronary Intervention

Canada
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Completed

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk (RAPID MANAGE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada
Population Health Research Institute
Heart and Stroke Foundation of Canada

Recruiting

Adjunctive, Low-dose tPA in Primary PCI for STEMI (STRIVE)

Myocardial Infarction | Percutaneous Coronary Intervention

Canada
Unity Health Toronto

Completed

Mechanical Ventilation Discontinuation Practices (IOS)

Critical Illness | Tracheostomy | Spontaneous Breathing Trial | Invasive Mechanical Ventilation | Weaning Invasive Mechanical Ventilation | Direct Extubation

United States, Canada
Ottawa Heart Institute Research Corporation
Spartan Bioscience Inc.

Completed

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (RAPID GENE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Stable Coronary Artery Disease

Canada
Vancouver Island Health Authority

Completed

Surgery and Neuroablative Procedures in Spasticity

Surgery | Upper Extermity Spasticity | Multidisciplinary Approach | Novel Algorithm | Diagnostic Nerve Block | Percutaneous Neuroablative Procedures | Refractory Spasticity

Canada
Population Health Research Institute
Sanofi

Completed

A Trial of Trans-radial Versus Trans-femoral Percutaneous Coronary Intervention (PCI) Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy (RIVAL)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada
University Health Network, Toronto
Stony Brook University; York University

Completed

Cardiac Rehabilitation Peer Mentorship

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Chronic Stable Heart Failure | Coronary Artery Bypass Graft Surgery, With or Without Valve Surgery

Canada
University Health Network, Toronto

Not yet recruiting

Canadian Adult Congenital Heart Disease Intervention Registry (C-ACHDiR)

Atrial Septal Defect | Tetralogy of Fallot | Transposition of Great Vessels | Patent Foramen Ovale | Coarctation of Aorta | Fontan | Percutaneous Pulmonary Valve Implantation

Canada
Queen Elizabeth II Health Sciences Centre
Nova Scotia Health Research Foundation

Completed

Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients (PPAR-G)

Coronary Artery Disease | Type 2 Diabetes Mellitus | Angina Pectoris | Percutaneous Coronary Intervention

Canada
Janssen Scientific Affairs, LLC
Bayer

Completed

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

United States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
Boehringer Ingelheim

Completed

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

Canada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
Faraday Pharmaceuticals, Inc.

Recruiting

Evaluation in STEMI Patients Using FDY-5301 (IOCYTE AMI-3)

Acute Myocardial Infarction | STEMI | Percutaneous Coronary Revascularization

United States, Israel, Poland, Portugal, Hungary, Canada
Fundación EPIC

Recruiting

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction

Spain
Population Health Research Institute

Completed

A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI (TOTAL)

ST Elevation Myocardial Infarction | Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada, United States, Korea, Republic of, United Kingdom, Spain, New Zealand, France, Greece, Austria, Netherlands, Germany, Finland, Serbia, Czech Republic, Australia, Hungary, Brazil, Belgium, China, Macedonia, The Former Yugoslav...
Cogentus Pharmaceuticals

Terminated

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) (COGENT-1)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

United States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine

Clinical Trials on Percutaneous Tracheostomy in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations